How are Auckland Surgeons Managing the Axilla? E Whineray Kelly, O Pellet, L Neave, J Harman, R Harman. Auckland Breast Cancer Study Group.

Slides:

Advertisements

Similar presentations

Jayant S Vaidya What is the best way to treat the axilla? 19th century

Advertisements

Dr Cheung Chi Ying Genevieve

Evidence for adjuvant radiation therapy benefiting breast cancer patients with 1 to 3 positive lymph nodes treated with a modified radical mastectomy and.

Pimp Session: Breast By James Lee, MD.

Neo-adjuvant Chemotherapy for Breast Cancer

Breast Cancer. Introduction Most common female cancer Accounts for 32% of all female cancer 211,300 new cases yearly and rising 40,000 deaths yearly.

Contraindications to sentinel lymph node biopsy Martine Berliere GGOLFB Breast Clinic Cancer Center Cliniques Universitaires St Luc.

DCIS – Are we cutting it? Dr Alex Lemaigre With thanks to:

Breast Cancer in Pregnancy

Role of Nodal Irradiation in Breast Cancer

Current Management of the Axilla in Breast Cancer Joint Hospital Surgical Grand Round 25 th July, 2009 Princess Margaret Hospital Law Hang Sze.

An update for Illinois Nurses Elizabeth A. Peralta, MD The Breast Center at SIU Springfield, IL May 2011.

Implications of NSABP B-32 and Loco-Regional Therapy Considerations After Neoadjuvant Chemotherapy Terry Mamounas, M.D., M.P.H, F.A.C.S. Professor of Surgery.

Giuliano Pre-SSO mins ASCO Z mins

Sentinel Lymph Node Biopsy in Melanoma

Breast Cancer Tumor Board Chair Harold Burstein, MD, PhD Faculty Jennifer Bellon, MD Mehra Golshan, MD.

S ENTINEL L YMPH N ODE M ICROMETASTASIS IN B REAST C ANCER Anthony Fong Yan Chai Hospital.

SON Breast Cancer Update: Current Controversies Oct 18, 2014 Who should we radiate and why? Lorna Weir Radiation Oncologist BC Cancer Agency, Vancouver.

Memorial Sloan-Kettering Cancer Center

Sentinel Lymph Node Dissection (SND)

Breast Cancer 101 Barbara Lee Bass, MD, FACS Professor of Surgery

Sentinel Lymph Node Concept; and Technique of SLN Identification in Breast Cancer Patients Dr S.Gambhir Department of Nuclear Medicine S.G.P.G.I.M.SLucknow.

Radiotherapy in Carcinoma of the Breast Patrick S Swift, MD Director, Radiation Oncology Alta Bates Comprehensive Cancer Center Berkeley, CA.

Hot topics in breast radiotherapy Mark Beresford.

Meta-analysis of trials of radiotherapy in DCIS Early Breast Cancer Trialists’ Collaborative Group (EBCTCG)

Neoadjuvant Chemotherapy for Ca Breast CY Choi UCH.

Breast Cancer - the Evidence for Current Management

Sentinel Node Biopsy : the way forward Hemant Singhal MS FRCSEd FRCS(Gen) FRCSC Consultant Surgeon Northwick Park & St Marks Hospital Senior Lecturer,

Racial/Ethnic Disparities in Cancer Incidence, Survival and Treatment Linda C. Harlan, PhD, MPH National Cancer Institute Division of Cancer Control and.

Treatment of Early Breast Cancer

Surgery Journal Club By : Ahmad Zahmatkesh Mohammadreza Nazemian.

How are we doing? Quality in Breast Cancer Care Dr Michelle Goecke Surgical Oncology Network Update October 18, 2014.

Ductal Carcinoma In Situ (DCIS)

Suggested guidelines for appropriate patient selection for patients undergoing Accelerated Partial Breast Irradiation at DMC. Tonya Echols Cole, MD.

Management of DCIS KWH Experience Dr. Carmen Ho.

Discussion abstracts Alberto Sobrero MD Ospedale San Martino Genoa, Italy.

Radiation Breast Oncology Highlights of SABC 2006 Alison Bevan, MD PhD UCSF Radiation Oncology January, 2007.

Quality Assurance Report TTUHSC Breast Center of Excellence January 1, 2013 – December 31, 2013 Compiled by Uzma Nazim, M.D.

A Glimpse of the Science Behind the American Cancer Society Access to Care Campaign Impact of Being Uninsured or Underinsured on Individuals with Cancer.

Clinical Trials Evaluating the Role of Sentinel Node Resection in Patients with Early-Stage Breast Cancer Krag DN et al. Proc ASCO 2010;Abstract LBA505.

Breast Cancer Risk with Menopausal Hormone Use Jackie Bouillon Advisor: Dr. Robert Hadley Spring 2007.

The Treatment of the Axilla in the North of England Cancer Network. Henry Cain ST7 North Tyneside.

TREATMENT Mastectomy -traditionally, treatment of breast ca has been surgical -19 century, surgical treatment : local excision ~ total mastectomy : radical.

Best first ? The ATAC completed treatment analysis Professor Jack Cuzick Wolfson Institute of Preventive Medicine, London, UK.

Radical Mastectomy is no longer the standard Improved adjuvant and neoadjuvant therapy Chemotherapy Endocrine therapy Radiation treatment Reconstruction.

Residents’ Journal Club Giao Q. Phan, M.D. September 4, 2014.

Quality Assurance Report TTUHSC Breast Center of Excellence January 1, 2009 – December 31, 2009.

Quality Assurance Report TTUHSC Breast Center of Excellence January 1, 2011 – December 31, 2011 Compiled by Lynn Day, RN BSN CCM CCRP.

Quality Assurance Report TTUHSC Breast Center of Excellence January 1, 2012 – December 31, 2012 Compiled by Uzma Nazim, M.D.

‘Arimidex’, Tamoxifen, Alone or in Combination (ATAC) trial: Completed Treatment Analysis.

SLNB The RUH experience A 2014 Audit Dr M Stoddart, Dr S Cole, Mr J Horsnell and Mr R Sutton Royal United Hospital, Bath.

Clinical Outcome of Reconstruction With Tissue Expanders for Patients With Breast Cancer and Mastectomy Mitsui Memorial Hospital Department of Breast and.

Basic Concepts Sentinel node biopsy is at least as good for axillary assessment as ALND and probably superior. Standard path evaluation for ALND yields.

Quality Assurance Report TTUHSC Breast Center of Excellence January 1, 2010 – December 31, 2010 Compiled by Lynn Day, RN BSN CCM CCRP.

Extranodal Extension on Sentinel Lymph Node Dissection: Why Should We Treat It Differently? Audrey Choi MD, Matthew Surrusco MD, Samuel Rodriguez MD, Khaled.

Basis and Outcome of Axillary Dissection for Node Negative Axilla Gurpreet Singh Dept. Of Surgery P.G.I.M.E.R. These Power Point presentations are free.

Treatment Options for Premenopausal Women With Early-Stage Hormone Receptor–Positive Breast Cancer Ongoing Studies This program is supported by an educational.

ABSTRACT Purpose This retrospective review was conducted to determine if delay in the start of radiotherapy after conservative breast surgery had any detrimental.

Adjuvant autologous renal tumour cell vaccine and risk of tumour progression in patients with renal- cell carcinoma after radical nephrectomy: phase III,

JHSGR 15/10/2016 Wong Lai Shan Tuen Mun Hospital

Copyright © 2013 American Medical Association. All rights reserved.

HER2 and estrogen receptor status drive decisions regarding the use of neoadjuvant chemotherapy Neil Love, MD1, Kimberly L Blackwell, MD2, Eleftherios.

Definitive Analysis of the Primary Outcomes

Prognosis of younger patients in non-small cell lung cancer

徐慧萍1 羅竹君1,2 郭耀隆1 李國鼎1 國立成功大學醫學院附設醫院外科部1 國立成功大學醫學院臨床醫學研究所2

Impact of the American College of Surgeons Oncology Group Z0011 Randomized Trial on the Number of Axillary Nodes Removed for Patients with Early-Stage.

Value in Health Regional Issues

Best Practices in Lymph Node Mapping and Localization: Melanoma

Presentation transcript:

How are Auckland Surgeons Managing the Axilla? E Whineray Kelly, O Pellet, L Neave, J Harman, R Harman. Auckland Breast Cancer Study Group

Axillary Lymph Nodes Staging√ Prognosis√ Adjuvant therapy√ Local control√ Overall survival???

Sentinel Node Biopsy Can be identified√ Reflects the status of the axilla√ False negative rate√ Increase axillary recurrence? Overall survival ?

What is the Auckland Practice? Auckland Breast Cancer Register Comprehensive database NZ residents with consent June 1 st 2000 Detailed information annually SNB data June 1 st Dec 2003 Data sent onto RACS audit

Results 2302 patients DCIS 285 Cancer treated non- surgically

DCIS 285 patients - 1 node positive

Cancer 1967 patients 688 node positive Total SNB570 SNACTrial data:16 SNAC enrolled AKL

Cancer

Sentinel Node Count 79%1-4 nodes 20 nodes nodes?? No early data available on method of detection

Follow-up

Local Recurrence After SNB LR after ALND0-21% (max f/u 180 months) LR after SNB/ % (max f/u 46 months) Veronesi % FN No LR in either arm

Local Recurrence After SNB MSKCC(2004)4008 SNB-/ No ALND0.12% SNB+/No ALND1.4%(210) ACOSOG Z0011 Trial

Does LR impact on survival? Controversial ! NSABP year f/u No survival advantage despite 17% difference on LR rate. Ragaz; Overgaard; Vinh-hung

Other issues…. Micrometastases ?upstaging with extensive SN analysis leading to over-treatment If SN negativity leads to less adjuvant treatment in the future, will the FN rate of 5% become more significant ?

Summary SNB accepted by surgeons and patients in Auckland region SN technique results: staging and prevention of LR is equivalent to ALND Long term survival data awaited